Michael Zinda Repare Therapeutics Inc. (RPTX) insider trading activity

Michael Zinda is EVP, CHIEF SCIENTIFIC OFFICER of Repare Therapeutics Inc.. Currently has a direct ownership of 80,297 shares of RPTX, which is worth approximately $96,356. The most recent transaction as insider was on Dec 22, 2020, when has been sold 41,312 shares (Common Stock) at a price of $1.85 per share, resulting in proceeds of $76,427. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.3K

11.67% 3M change

11.67% 12M change

Total Value Held $96,356

Michael Zinda Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2020	BUY Exercise of conversion of derivative security	$76,427 $1.85 p/Share	41,312 Added 24.61%	126,541 Common Stock
Dec 21 2020	SELL Open market or private sale	$1,323,200 $33.08 p/Share	40,000 Reduced 31.94%	85,229 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$96,800 $2.42 p/Share	40,000 Added 24.21%	125,229 Common Stock
Dec 18 2020	SELL Open market or private sale	$289,904 $34.84 p/Share	8,321 Reduced 8.89%	85,229 Common Stock
Dec 18 2020	BUY Exercise of conversion of derivative security	$17,141 $2.06 p/Share	8,321 Added 8.17%	93,550 Common Stock
Dec 16 2020	SELL Open market or private sale	$318,744 $35.59 p/Share	8,956 Reduced 9.51%	85,229 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	$14,688 $1.64 p/Share	8,956 Added 8.68%	94,185 Common Stock

Michael Zinda

EVP, CHIEF SCIENTIFIC OFFICER

St Laurent, A8

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Value

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX

Account